Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 18, 2024
Open Peer Review Period: Jul 24, 2024 - Jul 25, 2024
Date Accepted: Aug 1, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Stepped-Care Web-Based Parent Support Following Congenital Heart Disease: Protocol for a Randomized Controlled Trial

Taylor MM, Bondi BC, Andrade B, Au-Young S, Chau V, Danguecan A, Désiré N, Guo T, Ostojic-Aitkens D, Wade S, Miller S, Williams TS

Stepped-Care Web-Based Parent Support Following Congenital Heart Disease: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e64216

DOI: 10.2196/64216

PMID: 39365658

PMCID: 11489793

Stepped-care online parent support following congenital heart disease: Protocol for a randomized control trial

  • Marin Mackenzie Taylor; 
  • Bianca Christina Bondi; 
  • Brendan Andrade; 
  • Stephanie Au-Young; 
  • Vann Chau; 
  • Ashley Danguecan; 
  • Naddley Désiré; 
  • Ting Guo; 
  • Dragana Ostojic-Aitkens; 
  • Shari Wade; 
  • Steven Miller; 
  • Tricia Samantha Williams

ABSTRACT

Background:

Early neurodevelopmental risks, compounded with traumatic medical experiences, contribute to emotional and behavioural challenges in as many as 1 in 2 children with congenital heart disease (CHD). Parents report a strong need for supports; yet, there remains a lack of accessible, evidence-based behavioural interventions available for CHD children and families. I-InTERACT-North is an online stepped-care mental health program designed to support family well-being and reduce behavioural concerns through positive parenting for children with early medical complexity. In previous pilot studies, the program was effective in increasing positive parenting skills and decreasing child behaviour problems, with high parent-reported acceptability. The current paper presents the protocol for the first randomized study of stepped-care parent support for families of children with CHD.

Objective:

This study will involve a single-site, two-arm, single-blind randomized control trial (RCT) to evaluate 1) the feasibility and acceptability of an online stepped-care parent support program (I-InTERACT-North) and 2) the effectiveness of the program in enhancing positive parenting skills and reducing behavioural concerns among families of children with CHD.

Methods:

Families will be randomized (1:1) to either receive treatment or continue with care as usual (CAU) for 12 months. Randomization will be stratified by child’s sex assigned at birth and baseline parent-reported child behaviour intensity. Primary outcomes include positive parenting skills and child behaviour at baseline, 3 months, 6 months, and 12 months. Secondary outcomes include parental mental health, quality of life, service utilization, and feasibility including program reach and adherence.

Results:

A sample size of 244 families will provide >95% power to detect an effect size of d = .64. Based on attrition data from pilot studies, a target of 382 families will be enrolled. Recruitment began in February 2024, and recruitment and follow-up will continue until January 2029. We anticipate results in late 2029.

Conclusions:

This study will determine whether online stepped-care parent support is effective in improving positive parenting skills and child behaviour in families of children with CHD. Results will inform future clinical implementation and expansion of this program among families of children with early medical conditions. Clinical Trial: NCT06075251


 Citation

Please cite as:

Taylor MM, Bondi BC, Andrade B, Au-Young S, Chau V, Danguecan A, Désiré N, Guo T, Ostojic-Aitkens D, Wade S, Miller S, Williams TS

Stepped-Care Web-Based Parent Support Following Congenital Heart Disease: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2024;13:e64216

DOI: 10.2196/64216

PMID: 39365658

PMCID: 11489793

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.